Immunocore Holdings plc (ADR)

General ticker "IMCR" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.6B (TTM average)

Immunocore Holdings plc (ADR) follows the US Stock Market performance with the rate: 42.9%.

Estimated limits based on current volatility of 2.3%: low 30.53$, high 31.95$

Factors to consider:

  • Total employees count: 493 (-0.8%) as of 2024
  • US accounted for 91.5% of revenue in the fiscal year ended 2024-12-31
  • Top business risk factors: Operational and conduct risks, Regulatory and compliance, Market disruptions, Cybersecurity threats, Labor/talent shortage/retention
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [23.61$, 45.45$]
  • 2026-12-31 to 2027-12-31 estimated range: [23.45$, 45.41$]

Similar symbols

Short-term IMCR quotes

Long-term IMCR plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $249.43MM $247.77MM $297.57MM
Operating Expenses $309.08MM $304.05MM $331.31MM
Operating Income $-59.65MM $-56.28MM $-33.74MM
Non-Operating Income $-1.24MM $14.00MM $19.53MM
Interest Expense $5.15MM $18.84MM $12.17MM
R&D Expense $163.54MM $177.44MM $204.47MM
Income(Loss) $-60.89MM $-42.28MM $-14.21MM
Taxes $-5.60MM $-1.48MM $12.21MM
Profit(Loss)* $-67.21MM $-51.09MM $-26.42MM
Stockholders Equity $368.84MM $360.72MM $381.03MM
Inventory $4.50MM $5.45MM $6.74MM
Assets $597.00MM $1,009.51MM $1,067.27MM
Operating Cash Flow $2.94MM $26.06MM $-7.97MM
Capital expenditure $5.42MM $5.17MM $3.23MM
Investing Cash Flow $-5.42MM $-355.13MM $-12.16MM
Financing Cash Flow $34.35MM $343.88MM $9.20MM
Earnings Per Share** $-1.37 $-1.02 $-0.52
Ordinary share to ADR 1.00x 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.